Inside the Jan 2020 WIV Conference
(Work in Progress!)
The Feb 1 Teleconference was historic, but the January WIV Advisory Conference - a live event - predates that - it shaped it.
Think about it: if you entertain the possibility that Covid was a GoFFed-up WIV-exit event, then the contents of a WIV brainstrustBrains-trust meeting from Jan 11-14, right before the virus exploded onto the world,world stage, is big. It's, potentially,potentially:
the people who caused Covid conducting an emergency response plan to cover it up -
a plan that was dutifully followed/implemented by the world's leading experts, media, politicians, corporations, global bodies - the whole frightening world where One-Everything flexed its muscle:muscle ...
due to Covid
Linfa is Chairman of the Advisory Board - of all that.
We can assume the participants were the WIV higher-ups. SoSo, apart from Linfa & Zhengli, who are they?
Yuan Zhiming, Director of the Wuhan National Biosafety LaboratoryLaboratory, of the Wuhan Institute of VirologyWIV (AP Photo/Mark Schiefelbein)
Ph.D. biotechnology, Sun Yat-sen University, trained and rained/worked in France, Denmark, and United States
Deputy Director WIV since 2000 (pre-SARS), Focuses on: drug discovery of aborviruses, genomics, insecticidal proteins, genetic modification of Bacillus spp (a microbial agent similar to Anthrax)
2003-2003-present: Chairman Institutional Biosafety Committee, Group leader on the Sino-French biosafety legislation cooperation. Bear in mind this:
Gabriel Gras, French bio-security expert: (The BSL-4 lab) was built under the close cooperation between China and France. There is no doubt about its compliance with the highest international biosafety standards. The theory that the virus escaped from the Wuhan lab is not credible.
Xinhua: There is a "zero percent" chance that .. COVID-19 ..leaked from .. WIV (said) Gras .. (who) was employed as a technical expert at the French embassy in China for the implementation of the French-Chinese cooperation on emerging infectious diseases between 2012 and 2017
XinHua: During his stay in China, Gras participated in implementing the 2004 Sino-French Cooperation Agreement in Prevention and Control of Emerging Infectious Diseases, and supervised the construction and accreditation of the Wuhan Institute of Virology's BSL-4 laboratory in 2017.
Gras explained that operating a BSL-4 lab is very expensive. .. Coronaviruses, including the novel coronavirus, belong to BSL-3 or BSL-2 pathogens, rather than BSL-4 ones, and it is common sense that people will not use a BSL-4 facility to study BSL-3 pathogens or a BSL-3 facility to BSL-2 pathogens.
Gabriel Gras: Using a BSL-4 lab to work with a coronavirus is like using a 20-tonne crane to move a 30-kg refrigerator, which would be completely illogical.
Good point. Better explain that to Pete Daszak. He boasts they'd collected 15 000 bat virus samples at WIV, including RaTG13.
Was that also illogical?
WashPost: Yuan said at the (July 2020) news conference that his team took a virus database offline because of “the large number of malicious attacks,” and he complained that he and his colleagues are under great pressure from rumors.
Yuan Zhiming: I want to emphasize that .... the Wuhan Institute of Virology has never designed, made or leaked the novel coronaviruscoronavirus.
Re: WSJ leaked security report on sick researchers in Oct: I've read it, it's a complete lie.
Not sure i don't agree with him on that. If there really is a leaked US security report that sheds light on the origin of a humanity shaping bio-event, make it public. Why not?
Key points: Genetic modification specialist, WIV since pre-SARS, strong French connectionconnection, biosafety boss - if there was a leak , it was his fault.
Wang Yan-yi: Director General, WIV. The photo looks like she's about 17 years old but she's actually 40
PhDBSc (Beijing University), M.S. University(Colorado of ColoradoUni, School of Medicine,Medicine), BeforePhD joining(Wuhan theUni) Institutethen ofjoined Virology,WIV 2012
Young Scholar Awards 2013, 2014, WIV since 2012, Director since 2018
Involved in developmentthe promotion of antiviral drug Shuang-huang-lian, a Chinese traditional medicine patent, repurposed as a Covid treatementtreatment as early as Jan 31, 2020, causing a rush on the drug, though efficacy was later questioned.
Interestingly, Aa Chinese language article criticizes her as:
a post-80's woman who was relying on her husband's superior position
re her meteoric rise from completing her academic training at Wuhan University to WIV Director in 6 years.years. Her husband is Shu Hong-bing, a renowned scientist at Peking, then Wuhan Universities.Universities Where-where Yanyi received her BSc, then Phd, fromrespectively, thecoinciding samewith universities,Shu's respectively.tenures. (MSc Colorado, but she's not a full-on interfacer like theLinfa others.or Zhengli.)
In an NBC video, Aug 2020, Wang is asked: What is your theory on how the virus was able to make it to a city like Wuhan? Did you ever, at one point, worry that it might have come from your lab?
The response is great. She pauses to think - you can see her mind ticking over -her faint smile flickering - she remembers Shi Zhengli's answer - how that turned out ... her eyes roll top left - i know that means something- accessing a memory...
The faint smile returns like it never left as she lists off ways it could have arrived in Wuhan, including the Cold-Chain Hypothesis, then says:
Wang Yanyi (vid, 2:23): It's certainly impossible the virus was made by, or leaked by, the Wuhan Institute of Virology. We did not worry that the virus may have been leaked from the institute. Mainly because the management has always been very strict and standardized. In the past there have never been any bio-safety accidents such as pathogen leak, or even infection.
Key points: Fast-tracked millennial talent parachuted into management at WIV due partially to husband's influence - WIV benefited from promotion of dubious Covid treatment - not an interfacer
Wu-xiang Guan, Deputy Director General: MD and PhD (Chinese CDC), PI, Viral Replication and Posttranscriptional Regulation Group. BSc in Clinical Medicine (2000), MSc in Virology (2003),Tongji Medical University.
PhD awarded by Institute of Viral Disease Control and Prevention, Chinese CDC (2006).
Research in University of Kansas Medical Center (2007-2009), in Stowers Institute of Medical Research (2010-2012) before joining WIV in 2012 - same year as his boss.
Research: mechanisms of DNA replication of viruses, alternative polyadenylation regulation of viral mRNA and 3’ end biogenesis of noncoding RNA.
Key points: Looks like a gangster, he's researching mechanisms of DNA replication, mRNA tech. It's curious China didn't go the mRNA route with their vaccines. Surely they could have if they wanted to. Did they know something?
He Chang-cai, Deputy Secretary of the Party Committee, since 2013
Ichthyology (fish zoology), Chinese Academy of Sciences (CAS) from Jul. 1985 to Jun. 1996.
2000-2007, deputy head General Office of Education Center, then head 2001-2003, deputy head Office of Organization and Human Resources. 2008 to Aug. 2013, head of General Office, Office of Infrastructure, and assistant of the President of Wuhan Branch, CAS. since 2013, Corporate Secretary of the Party at Wuhan Branch from Oct. 2005 to Jul. 2013.
Key points: The CCP's man in WIV - same 80's graduate vintage as Linfa Wang
Gong Peng, Deputy Director General:
BSc (1998) and MSc (2001) in Chemistry from Tsinghua University, PhD (2002-2007) University of Massachusetts, Amherst, with Dr. Craig T Martin & Dr. Karsten. 2007-11, research with Dr. Olve B Peersen at Colorado State University. Joined WIV 2011.
Key Points: Interfacer -10 years at US universities,
So what advice did Linfa share as chair in a meeting with the above WIV heavyweights?
The following is an artistic rendering of what may have transpired ...
(Edit: No it's not. It's been split to a separate book where it's under construction. Instead we'll go straight to Linfa's involvement with the Lancet Statement.)